Usp Compounding Compendium Toc
Usp Compounding Compendium Toc
Contents
Introduction
USP Compounding Compendium.............................................................................................................................. 9
Section 1
Mission and Preface.................................................................................................................................................. 12
General Notices and Requirements........................................................................................................................... 17
Admissions and Annotated List of Changes............................................................................................................... 27
Section 2
á795ñ Pharmaceutical Compounding—Nonsterile Preparations................................................................................. 29
á797ñ Pharmaceutical Compounding—Sterile Preparations....................................................................................... 36
á800ñ Hazardous Drugs—Handling in Healthcare Settings......................................................................................... 79
á825ñ Radiopharmaceuticals—Preparation, Compounding, Dispensing, and Repackaging ....................................... 96
á1160ñ Pharmaceutical Calculations in Pharmacy Practice....................................................................................... 124
á1163ñ Quality Assurance in Pharmaceutical Compounding.................................................................................... 149
á1168ñ Compounding for Phase I Investigational Studies........................................................................................ 156
á1176ñ Prescription Balances and Volumetric Apparatus Used in Compounding...................................................... 164
Section 3
á7ñ Labeling............................................................................................................................................................ 171
á31ñ Volumetric Apparatus...................................................................................................................................... 178
á41ñ Balances.......................................................................................................................................................... 179
á51ñ Antimicrobial Effectiveness Testing.................................................................................................................. 180
á61ñ Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests........................................... 182
á62ñ Microbiological Examination of Nonsterile Products: Tests for Specified Microorganisms................................. 188
á71ñ Sterility Tests................................................................................................................................................... 197
á85ñ Bacterial Endotoxins Test................................................................................................................................. 204
á151ñ Pyrogen Test................................................................................................................................................. 209
á381ñ Elastomeric Components in Injectable Pharmaceutical Product Packaging/Delivery Systems ......................... 211
á659ñ Packaging and Storage Requirements............................................................................................................ 214
á660ñ Containers—Glass......................................................................................................................................... 220
á661ñ Plastic Packaging Systems and Their Materials of Construction...................................................................... 226
á661.1ñ Plastic Materials of Construction................................................................................................................. 233
á661.2ñ Plastic Packaging Systems for Pharmaceutical Use...................................................................................... 261
á671ñ Containers—Performance Testing.................................................................................................................. 265
á731ñ Loss On Drying.............................................................................................................................................. 273
á785ñ Osmolality and Osmolarity............................................................................................................................ 274
á821ñ Radioactivity.................................................................................................................................................. 284
á823ñ Positron Emission Tomography Drugs for Compounding, Investigational, and Research Uses........................ 290
á1066ñ Physical Environments That Promote Safe Medication Use........................................................................... 299
á1072ñ Disinfectants and Antiseptics....................................................................................................................... 311
á1079ñ Risks and Mitigation Strategies for the Storage and Transportation of Finished Drug Products..................... 316
á1079.1ñ Storage and Transportation of Investigational Drug Products................................................................... 328
á1079.2ñ Mean Kinetic Temperature in the Evaluation of Temperature Excursions During Storage and Transportation of
Drug Products.......................................................................................................................................... 331
á1111ñ Microbiological Examination of Nonsterile Products: Acceptance Criteria for Pharmaceutical Preparations and
Substances for Pharmaceutical Use........................................................................................................... 334
á1113ñ Microbial Characterization, Identification, and Strain Typing....................................................................... 335
á1116ñ Microbiological Control and Monitoring of Aseptic Processing Environments.............................................. 339
á1151ñ Pharmaceutical Dosage Forms..................................................................................................................... 351
á1178ñ Good Repackaging Practices........................................................................................................................ 374
á1191ñ Stability Considerations in Dispensing Practice............................................................................................ 375
á1211ñ Sterility Assurance........................................................................................................................................ 380
á1229.5ñ Biological Indicators for Sterilization......................................................................................................... 388
á1231ñ Water for Pharmaceutical Purposes.............................................................................................................. 391
á1251ñ Weighing On An Analytical Balance............................................................................................................. 425
á1265ñ Written Prescription Drug Information—Guidelines..................................................................................... 430
á1821ñ Radioactivity—Theory and Practice.............................................................................................................. 432
4 Contents June 2020 / USP Compounding Compendium
Section 4
Acacia Syrup........................................................................................................................................................... 446
Acetazolamide Compounded Oral Suspension........................................................................................................ 446
Diluted Acetic Acid................................................................................................................................................. 446
Acetylcysteine Compounded Solution..................................................................................................................... 447
Alcohol................................................................................................................................................................... 448
Diluted Alcohol....................................................................................................................................................... 450
Allopurinol Compounded Oral Suspension............................................................................................................. 450
Alprazolam Compounded Oral Suspension............................................................................................................. 451
Aluminum Acetate Topical Solution........................................................................................................................ 451
Aluminum Subacetate Topical Solution................................................................................................................... 452
Amiodarone Hydrochloride Compounded Oral Suspension.................................................................................... 453
Amlodipine Compounded Oral Suspension............................................................................................................. 453
Anticoagulant Citrate Dextrose Solution................................................................................................................. 454
Anticoagulant Citrate Phosphate Dextrose Solution................................................................................................ 455
Anticoagulant Citrate Phosphate Dextrose Adenine Solution................................................................................... 457
Anticoagulant Sodium Citrate Solution................................................................................................................... 458
Arginine Hydrochloride Compounded Oral Solution............................................................................................... 459
Aromatic Elixir........................................................................................................................................................ 460
Ascorbic Acid Compounded Oral Solution.............................................................................................................. 460
Atenolol Compounded Oral Solution...................................................................................................................... 461
Atenolol Compounded Oral Suspension................................................................................................................. 461
Atenolol Compounded Oral Suspension, Veterinary................................................................................................ 462
Azathioprine Compounded Oral Suspension........................................................................................................... 462
Baclofen Compounded Oral Suspension................................................................................................................. 463
Beclomethasone Dipropionate Compounded Oral Solution.................................................................................... 464
Belladonna Tincture................................................................................................................................................ 464
Benazepril Hydrochloride Compounded Oral Suspension, Veterinary...................................................................... 465
Bentonite Magma................................................................................................................................................... 465
Compound Benzaldehyde Elixir.............................................................................................................................. 466
Benzethonium Chloride Tincture............................................................................................................................ 466
Compound Benzoin Tincture.................................................................................................................................. 467
Benzyl Benzoate Lotion........................................................................................................................................... 467
Bethanechol Chloride Compounded Oral Solution.................................................................................................. 467
Bethanechol Chloride Compounded Oral Suspension............................................................................................. 468
Biotin Compounded Oral Suspension..................................................................................................................... 468
Milk of Bismuth...................................................................................................................................................... 469
Buprenorphine Compounded Buccal Solution, Veterinary....................................................................................... 470
Calamine Topical Suspension.................................................................................................................................. 470
Phenolated Calamine Topical Suspension............................................................................................................... 471
Calcium Hydroxide Topical Solution....................................................................................................................... 471
Camphor Spirit....................................................................................................................................................... 471
Captopril Compounded Oral Solution.................................................................................................................... 471
Captopril Compounded Oral Suspension................................................................................................................ 472
Carbol-Fuchsin Topical Solution.............................................................................................................................. 473
Carboxymethylcellulose Sodium Compounded Intraperitoneal Solution, Veterinary................................................ 473
Compound Cardamom Tincture............................................................................................................................. 474
Aromatic Cascara Fluidextract................................................................................................................................. 474
Cefazolin Ophthalmic Solution............................................................................................................................... 474
Cherry Juice............................................................................................................................................................ 475
Cherry Syrup.......................................................................................................................................................... 476
Chlorambucil Compounded Oral Suspension......................................................................................................... 476
Chloramphenicol Compounded Oral Suspenstion, Veterinary................................................................................. 477
Chloroquine Phosphate Compounded Oral Suspension.......................................................................................... 478
Chlorothiazide Compounded Oral Suspension........................................................................................................ 478
Chocolate Syrup..................................................................................................................................................... 479
Cisapride Compounded Injection, Veterinary.......................................................................................................... 479
Cisapride Compounded Oral Suspension, Veterinary.............................................................................................. 480
Clindamycin Hydrochloride Compounded Oral Solution......................................................................................... 481
Compound Clioquinol Topical Powder................................................................................................................... 481
Clomipramine Hydrochloride Compounded Oral Suspension, Veterinary................................................................ 482
Clonazepam Compounded Oral Suspension........................................................................................................... 483
Clonidine Hydrochloride Compounded Oral Suspension......................................................................................... 483
Clopidogrel Compounded Oral Suspension............................................................................................................ 484
Coal Tar Ointment.................................................................................................................................................. 485
Coal Tar Topical Solution........................................................................................................................................ 485
Cocaine and Tetracaine Hydrochlorides and Epinephrine Topical Solution.............................................................. 485
Codeine Phosphate Compounded Oral Solution..................................................................................................... 487
Collodion................................................................................................................................................................ 487
June 2020 / USP Compounding Compendium Contents 5